A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine

Recombinant protein vaccines, with highly pure ingredients and good safety, are gradually replacing some attenuated and inactivated vaccines in clinical practice. However, since their low immunogenicity of the recombinant proteins, adjuvants are often needed to enhance immune response after vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Pu, Wang, Zhibiao, Li, Jilai, Wei, Duoqian, Zhang, Zhuan, Hao, Shaojie, Hou, Yibo, Wang, Yunyang, Li, Shuxiang, Wang, Xudong, Xu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127465/
https://www.ncbi.nlm.nih.gov/pubmed/35620473
http://dx.doi.org/10.3389/fbioe.2022.903424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127465/
https://www.ncbi.nlm.nih.gov/pubmed/35620473
http://dx.doi.org/10.3389/fbioe.2022.903424

Ejemplares similares